Treating menorrhagia in primary care

International Journal of Technology Assessment in Health Care

Volumn 11, Issue 3, 1995, Pages 456-471

  Coulter, Angela ^a   Kelland, Joanne ^b   Peto, Viv ^c   Rees, Margaret C P ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; CLOMIFENE; DANAZOL; DICLOFENAC; DYDROGESTERONE; ETAMSYLATE; FLURBIPROFEN; GESTRINONE; GONADORELIN DERIVATIVE; LEVONORGESTREL; MECLOFENAMIC ACID; MEDROXYPROGESTERONE; MEFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; TRANEXAMIC ACID;

CLINICAL PRACTICE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; GENERAL PRACTICE; HEADACHE; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; META ANALYSIS; MYALGIA; PRESCRIPTION; PRIMARY MEDICAL CARE; PRURITUS; RASH; REVIEW; STOMACH PAIN; VAGINITIS;

ADULT; CLINICAL TRIALS; COMPARATIVE STUDY; ENGLAND; FAMILY PRACTICE; FEMALE; HUMAN; MENORRHAGIA; MIDDLE AGE; PHYSICIAN'S PRACTICE PATTERNS; RANDOMIZED CONTROLLED TRIALS;

EID: 0029115483     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462300008679     Document Type: Article

References (46)

1. Andersch, B., Milson, I., & Rybo, G. An objective evaluation of flurbiprofen and tranex-amic acid in the treatment of idiopathic menorrhagia. Acta Obstetricia et Gynecologica Scandinavica, 1988, 67, 645–48.
2. Bonnar, J. Seminar on dysfunctional uterine bleeding (unpublished). London: The Royal Society of Medicine, 1994.
3. Callender, S., Warner, G., & Cope, E. Treatment of menorrhagia with tranexamic acid: A double-blind trial. British Medical Journal, 1970, 4, 214–216.
4. Cameron, I., Haining, R., Lumsden, M.-A., et al. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstetrics and Gynecology, 1990, 76, 85–88.
5. Cameron, I., Leask, R., Kelly, R., & Baird D. The effects of danazol, mefenamic acid, norethisterone, and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins, 1987, 34, 99–110.
6. Chamberlain, G., Freeman, R., Price, F., et al. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology, 1991, 98, 707–711.
7. Chimbira,T., Anderson, A., Naish,C.,etal. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: Lack of effect of placebo. British Journal of Obstetrics and Gynaecology, 1980, 87, 1152–1158.
8. Chimbira, T., Anderson, A., & Turnbull, A. Relation between measured menstrual blood loss and patient’s subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. British Journal of Obstetrics and Gynaecology, 1980, 87, 603–609.
9. Coulter, A., Klassen, A., MacKenzie, I., & McPherson, K. Diagnostic dilatation and curettage: Is it used appropriately? British Medical Journal, 1993, 306, 236–239.
10. Coulter, A., Klassen, A., & McPherson, K. How many hysterectomies should purchasers buy? European Journal of Public Health, in press, 1995.
11. Coulter, A., & McPherson, K. The hysterectomy debate. Quarterly Journal of Social Affairs, 1986, 2, 379–396.
12. Davis, A., Anderson, A., & Turnbull, A. Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices. Obstetrics and Gynecology, 1981,57,74-78.
13. Dockeray, C., Shephard, B., & Bonnar, J. Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. British Journal of Obstetrics and Gynaecology, 1989, 96, 840–844.
14. Fraser, I., & McCarron, G. Randomized trial of two hormonal and two prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Australian New Zealand Journal of Obstetrics and Gynaecology, 1991, 31, 66–70.
15. Fraser, I., McCarron, G., & Markham, R. A preliminary study of factors influencing perception of menstrual blood loss volume. American Journal of Obstetrics, 1984, 149, 788–93.
16. Fraser, I., Pearse, C., Shearman, R., et al. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics and Gynecology, 1981, 58, 543–51.
17. Gallegos, A., Aznar, R., Merino, G., & Guizer, E. Intrauterine devices and menstrual blood loss: A comparative study of eight devices during the first six months of use. Contraception, 1978, 17, 153–61.
18. Guillebaud, I., Anderson, A., & Turnball, A. Reduction by mefenamic acid of increased menstrual blood loss associated with intrauterine contraception. British Journal of Obstetrics and Gynaecology, 1978, 85, 53–62.
19. Hall, P., MacLachlan, N., Thorn, N., et al. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxan sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology, 1987, 94, 554–58.
20. Hallberg, L., Hogdahl, A., Nilsson, L., & Rybo, G. Menstrual blood loss: A population study. Acta Obstetrica Gynecologica Scandinavica, 1966, 45, 320–51.
21. Hallberg, L., & Nilsson, L. Determination of menstrual blood loss. Scandinavian Journal of Clinical & Laboratory Investigation, 1964, 16, 244–48.
22. Harrison, R., & Campbell, S. A double-blind trial by ethamsylate in the treatment of primary and intrauterine device menorrhagia. Lancet, 1976, ii, 283–85.
23. Haynes, P., Anderson, A., & Turnbull, A. Patterns of menstrual blood loss in menorrhagia. Research and Clinical Forums, 1979, 1, 73–78.
24. Haynes, P., Hodgson, H., Anderson, A., & Turnbull, A. Measurement of menstrual blood loss in patients complaining of menorrhagia. British Journal of Obstetrics and Gynaecology, 1977, 84, 763–68.
25. Higham, I., & Shaw, R. A comparative study of danazol, a regimen of decreasing doses of danazol and norethindrone in the treatment of objectively proven unexplained menorrhagia. American Journal of Obstetrics and Gynecology, 1993, 169, 1134–39.
26. Ingemanson, C., Sikstrom, B., Rybo, G., & Bjorkman, R. Double-blind, placebo-controlled evaluation of diclofenac in the management of patients with IUD-related menorrhagia. Advanced Therapeutics, 1991, 8, 287–92.
27. Intercontinental medical statistics (IMS), UK & Ireland Ltd., 1994.
28. Kasonde, J., & Bonnar, J. Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices. British Medical Journal, 1975, 2, 21–22.
29. Macdonald, R. Modern treatment of menorrhagia. British Journal of Obstetrics and Gynaecology, 1990, 97, 3–7.
30. Makarainen, L., & Ylikorkala, O. Primary and myoma-associated menorrhagia: Role of prostaglandins and effects of ibuprofen. British Journal of Obstetrics and Gynaecology, 1986, 93, 974–78.
31. Milsoo, I., Andersson, K., Andersch, B., & Rybo, G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology, 1991, 164, 879–83.
32. Muggeridge, J., & Elder, M. Mefenamic acid in the treatment of menorrhagia. Research and Clinical Forums, 1983, 5, 83–88.
33. Nilsson, C. Comparative quantitation of menstrual blood loss withad-norgestrel-releasing IUD and a Nova-T-copper device. Contraception, 1977, 15, 379–87.
34. Nilsson, L., & Rybo, G. Treatment of menorrhagia with an antifibrinolytic agent, tranex-amic acid (AMCA): A double-blind investigation. Acta Obstetricia et Gynecologica Scan-dinavica, 1967, 46, 572–80.
35. Preston, J., Cameron, I., Adams, E., & Smith, S. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. British Journal of Obstetrics and Gynaecology, 1995, 102,401-06.
36. Rees, M. Role of menstrual blood loss measurement in management of complaints of excessive menstrual bleeding. British Journal of Obstetrics and Gynaecology, 1991, 98, 327–28.
37. Rees, M., Canate-Soler, R., Lopez-Bernal, A., & Turnbull, A. Effect of fenamates on prostaglandin E receptor binding. Lancet, 1988, ii, 541–42.
38. Roy, S., & Shaw, S. Role of prostaglandins in IUD-associated uterine bleeding: Effect of a prostaglandin synthetase (ibuprofen). Obstetrics and Gynecology, 1981, 58, 101–106.
39. Rybo, G. Tranexamic acid therapy effective treatment in heavy menstrual bleeding: Clinical update on safety. Therapeutic Advances, 1991, 4, 1–8.
40. Rybo, G., Nilsson, S., Sikstrom, B., & Nygren, K. Naproxen in menorrhagia (letter). Lancet, 1981, i, 608–609.
41. Van Eijkeren, M., Christiaens, G., Gueze, H., & Sixma, J. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology, 1992, 166, 1419–28.
42. Vargyas, J., Campeau, J., & Mishell, D. Treatment of menorrhagia with meclofenamate sodium. American Journal of Obstetrics and Gynecology, 1987, 157, 944–50.
43. Vermylen, J., Verhaegen-Declercq, M., Verstraete, M., & Fierens, F. A double-blind study of the effect of tranexamic acid in essential menorrhagia. Thrombosis et Diathesis Haemorrhagica, 1968, 20, 583–87.
44. Vessey, M., Villard-Mackintosh, L., McPherson, K., Coulter, A., & Yeates, D. The epidemiology of hysterectomy: Findings in a large cohort study. British Journal of Obstetrics and Gynaecology, 1992, 99, 402–407.
45. Ylikorkala, O., & Pekonen, F. Naproxen reduced idiopathic but not fibroma-induced menorrhagia. Obstetrics and Gynecology, 1986, 68, 10–12.
46. Ylikorkala, O., & Viinikka, L. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. British Journal of Obstetrics and Gynaecology, 1983, 90, 78–83.